Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
2,019 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00280709 | Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary Obstruction | completed | Phase 4 | 400 | University Hospital, LinkoepingOTHER | 1 | Aug 10, 2011 | clinicaltrials |
| NCT00790244 | A Scandinavian Sarcoma Group Protocol for Patients With High-risk Soft Tissue Sarcoma of the Extremities and Trunk Wall(SSGXX) | unknown | Phase 2 | 188 | Oslo University HospitalOTHER | 1 | Jul 6, 2011 |
| clinicaltrials |
| NCT00489359 | Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer | completed | Phase 1 / Phase 2 | 86 | Eli Lilly and CompanyINDUSTRY | 5 | Jun 16, 2011 | clinicaltrials |
| NCT01351974 | Sentinel Node Biopsy in Breast Cancer Patients | completed | — | 3,369 | Uppsala UniversityOTHER | 1 | May 30, 2011 | clinicaltrials |
| NCT00076388 | Iressa Versus Docetaxel (Taxotere) | completed | Phase 3 | 1,440 | AstraZenecaINDUSTRY | 25 | May 13, 2011 | clinicaltrials |
| NCT00006479 | Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer | unknown | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 13 | Apr 18, 2011 | clinicaltrials |
| NCT00101647 | Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia | completed | Phase 2 | 197 | Bristol-Myers SquibbINDUSTRY | 23 | Apr 15, 2011 | clinicaltrials |
| NCT00101595 | Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia | completed | Phase 2 | 96 | Bristol-Myers SquibbINDUSTRY | 20 | Apr 14, 2011 | clinicaltrials |
| NCT00179621 | Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] Abnormality | completed | Phase 3 | 205 | Celgene CorporationINDUSTRY | 9 | Apr 14, 2011 | clinicaltrials |
| NCT00386685 | XRP9881 in Combination With Trastuzumab in Metastatic Breast Cancer | completed | Phase 2 | 51 | SanofiINDUSTRY | 4 | Apr 12, 2011 | clinicaltrials |
| NCT00500968 | Study Assessing the Effect of Transpapillary Pancreas Duct Stent in Resection of the Pancreatic Tail | completed | N/A | 50 | Karolinska InstitutetOTHER | 1 | Apr 7, 2011 | clinicaltrials |
| NCT00417079 | XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer(TROPIC) | completed | Phase 3 | 755 | SanofiINDUSTRY | 26 | Mar 10, 2011 | clinicaltrials |
| NCT01303393 | Information Needs After Surgery for Colorectal Cancer | completed | — | 100 | Region SkaneOTHER | 1 | Feb 24, 2011 | clinicaltrials |
| NCT00688740 | Docetaxel in Node Positive Adjuvant Breast Cancer(TAX316) | completed | Phase 3 | 1,491 | SanofiINDUSTRY | 20 | Feb 16, 2011 | clinicaltrials |
| NCT00602511 | Thalidomide Versus Bortezomib in Melphalan Refractory Myeloma | completed | Phase 3 | 300 | Nordic Myeloma Study GroupOTHER | 3 | Feb 9, 2011 | clinicaltrials |
| NCT00206219 | Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX) | completed | Phase 3 | 477 | AstraZenecaINDUSTRY | 25 | Jan 27, 2011 | clinicaltrials |
| NCT00239343 | Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast Cancer | completed | Phase 2 | 160 | AstraZenecaINDUSTRY | 3 | Jan 27, 2011 | clinicaltrials |
| NCT00238797 | A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme | completed | Phase 2 | 36 | AstraZenecaINDUSTRY | 1 | Jan 21, 2011 | clinicaltrials |
| NCT01259934 | Nordic Adjuvant IFN Melanoma Trial | completed | Phase 3 | 855 | Karolinska InstitutetOTHER | 1 | Dec 14, 2010 | clinicaltrials |
| NCT00829192 | Phase II AK Study in Organ Transplant Patients | unknown | Phase 2 | 200 | Clinuvel Pharmaceuticals LimitedINDUSTRY | 7 | Dec 6, 2010 | clinicaltrials |
| NCT01227356 | A Study Comparing Imatinib and Imatinib/Pegylated Interferon in Chronic Myeloid Leukemia | completed | Phase 2 | 112 | Uppsala UniversityOTHER | 1 | Oct 25, 2010 | clinicaltrials |
| NCT00895674 | Patient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With Nexavar | completed | — | 2,840 | BayerINDUSTRY | 18 | Sep 30, 2010 | clinicaltrials |
| NCT00143403 | Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer | completed | Phase 3 | 321 | PfizerINDUSTRY | 16 | Sep 28, 2010 | clinicaltrials |
| NCT00966173 | International Melanoma Algorithm Training Study - IMATS | completed | N/A | 1,800 | SciBase ABOTHER | 1 | Aug 11, 2010 | clinicaltrials |
| NCT00101816 | Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate | completed | Phase 2 | 124 | Bristol-Myers SquibbINDUSTRY | 20 | Aug 10, 2010 | clinicaltrials |
| NCT00103844 | Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia | completed | Phase 2 | 150 | Bristol-Myers SquibbINDUSTRY | 32 | Aug 10, 2010 | clinicaltrials |
| NCT00417911 | Efficacy of Bortezomib Consolidation After High-dose Melphalan With Stem Cell Support in Myeloma Patients | completed | Phase 3 | 400 | Nordic Myeloma Study GroupOTHER | 5 | Jun 22, 2010 | clinicaltrials |
| NCT00508209 | Bortezomib and High-dose Melphalan at Myeloma Relapse | unknown | Phase 2 | 50 | Nordic Myeloma Study GroupOTHER | 3 | Jun 22, 2010 | clinicaltrials |
| NCT00002926 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia | unknown | Phase 3 | 80 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | May 27, 2010 | clinicaltrials |
| NCT00671996 | Mangafodipir as an Adjunct to FOLFOX6 Chemotherapy in Colon Cancer Stage Dukes' C(MANFOL) | completed | Phase 2 | 14 | Egetis TherapeuticsINDUSTRY | 1 | May 4, 2010 | clinicaltrials |
| NCT00063141 | Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer | completed | Phase 3 | 1,302 | Eli Lilly and CompanyINDUSTRY | 17 | Apr 12, 2010 | clinicaltrials |
| NCT00101608 | Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium | completed | Phase 2 | 150 | Bristol-Myers SquibbINDUSTRY | 15 | Mar 2, 2010 | clinicaltrials |
| NCT00991250 | SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma | unknown | Phase 2 | 140 | SentoClone ABINDUSTRY | 1 | Feb 5, 2010 | clinicaltrials |
| NCT00891748 | Safety Study on AdCD40L Gene Therapy for Bladder Cancer | completed | Phase 1 / Phase 2 | 12 | Uppsala UniversityOTHER | 1 | Jan 18, 2010 | clinicaltrials |
| NCT00383695 | Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal Cancer(EXPERT-C) | unknown | Phase 2 | 164 | Royal Marsden NHS Foundation TrustOTHER | 3 | Jan 13, 2010 | clinicaltrials |
| NCT01045200 | Nurse-or Surgeon-led Follow-up After Rectal Cancer | completed | — | 110 | Centrallasarettet VästeråsOTHER | 1 | Jan 8, 2010 | clinicaltrials |
| NCT00291577 | Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer | completed | Phase 1 | 22 | PfizerINDUSTRY | 3 | Dec 23, 2009 | clinicaltrials |
| NCT00484705 | Polycystic Ovary Syndrome (PCOS) - Effect Of Physical Exercise And Electroacupuncture(PCOSNTS) | completed | N/A | 84 | Göteborg UniversityOTHER | 1 | Nov 10, 2009 | clinicaltrials |
| NCT00090038 | Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma | completed | Phase 4 | 168 | BiogenINDUSTRY | 11 | Oct 20, 2009 | clinicaltrials |
| NCT00997633 | Single-photon Emission Computed Tomography (SPECT) to Predict Peritoneal Chemotherapy | completed | — | 51 | Uppsala UniversityOTHER | 1 | Oct 19, 2009 | clinicaltrials |
| NCT00997048 | Comparison Between Laying Open and Sinus Excision of Pilonidal Sinus - a Randomized Study | completed | N/A | 80 | Uppsala UniversityOTHER | 1 | Oct 16, 2009 | clinicaltrials |
| NCT00143312 | Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants(VOSIFI) | completed | Phase 4 | 45 | PfizerINDUSTRY | 8 | Oct 6, 2009 | clinicaltrials |
| NCT00137423 | Study Of SU011248 (Sunitinib) Given In A Continuous Daily Regimen In Patients With Advanced Renal Cell Cancer | completed | Phase 2 | 107 | PfizerINDUSTRY | 7 | Sep 30, 2009 | clinicaltrials |
| NCT00931190 | Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical Dysplasia | completed | — | 195 | Lund UniversityOTHER | 1 | Sep 15, 2009 | clinicaltrials |
| NCT00329615 | Insulin Treatment in Cancer Cachexia | completed | Phase 4 | 135 | Göteborg UniversityOTHER | 1 | Aug 21, 2009 | clinicaltrials |
| NCT00681486 | Ghrelin - A Possible Opportunity to Improve Appetite(Phase 3) | completed | Phase 3 | 30 | Göteborg UniversityOTHER | 1 | Aug 21, 2009 | clinicaltrials |
| NCT00330915 | A Study of Pemetrexed and Folic Acid Given Before Surgery (Neoadjuvant Treatment) to Patients With Rectal Cancer. | completed | Phase 2 | 37 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 21, 2009 | clinicaltrials |
| NCT00300729 | Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy(CYCLUS) | unknown | Phase 3 | 319 | University Hospital, LinkoepingOTHER | 1 | Jun 30, 2009 | clinicaltrials |
| NCT00672282 | Casodex vs Placebo in Non-Metastatic Early Prostate Cancer(SPCG6) | completed | Phase 3 | 1,218 | AstraZenecaINDUSTRY | 4 | May 27, 2009 | clinicaltrials |
| NCT00255463 | Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study | completed | Phase 2 | 185 | AstraZenecaINDUSTRY | 7 | Apr 23, 2009 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials